HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia
- 16 July 2009
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 361 (3), 271-278
- https://doi.org/10.1056/nejmct0806938
Abstract
A sexually active 18-year-old woman presents to her internist for an annual examination and asks whether she should receive the human papillomavirus (HPV) vaccine. HPV causes cervical cancer. Currently available vaccines provide protection against some but not all oncogenic genotypes of the virus if the recipient has not previously been infected. Regular cervical-cancer screening is still required for vaccine recipients.This publication has 48 references indexed in Scilit:
- Immunobiology of HPV and HPV vaccinesGynecologic Oncology, 2008
- Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex PartnerThe Journal of Infectious Diseases, 2008
- Prevalence of HPV Infection Among Females in the United StatesJAMA, 2007
- Annual productivity costs due to cervical cancer mortality in the United StatesWomen's Health Issues, 2006
- Reducing global disease burden of measles and rubella: Report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005Vaccine, 2006
- Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in ramsVaccine, 2006
- Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the USPharmacoEconomics, 2005
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosisPublished by Springer Science and Business Media LLC ,2000
- Epidemiology of Genital Human Papillomavirus InfectionAmerican Journal Of Medicine, 1997